Z-2245-2023 Class II Ongoing
FDA device recall Z-2245-2023 was initiated by Qiagen GmbH on May 19, 2023 and is designated Class II. Reason for recall: Identified a decreased performance reliability rate, Run abortions could cause delayed diagnosis since sample testing would have to be repeated The recall status is ongoing. Affected quantity: 386 kits.
Recall details
- Product Type
- Devices
- Report Date
- Aug 2, 2023
- Initiation Date
- May 19, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 386 kits
Product description
Reason for recall
Distribution pattern
DC, AL, CA, FL, GA, ME, NC, NY, OR, TX Foreign: DE, AE, AT, BE, BG, CH, CL, CY, CZ, DE, DK, ES, FI, FR, GB, GR, GT, HK, HU, ID, IN, IT, JO, MC, MU, MY, NL, NA, PL, PT, RO, SE, SK, TH, TN, TW, UY, YT, ZA
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2245-2023
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Qiagen GmbH? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.